What providers need to do to improve chronic care March 15, 2017 By Tracey Walker A West survey finds that an overwhelming number of chronic care patients say they need help managing their disease. How reducing pain of checking blood sugar lowers cost, improves outcomes Here are 3 reasons why overcoming the “fingerstick” barrier will improve patient outcomes and contribute to reductions in healthcare costs. Insurer diabetes program engages consumers, lowers costs Anthem Blue Cross recently launched a year-long diabetes prevention program to educate, treat and support its qualified California members who are at risk of developing type 2 diabetes. Aggressive blood sugar control slows diabetic eye disease progression NIH-funded study shows less diabetic retinopathy progression among those who underwent intensive glycemic control. Here's what docs don't know about diabetes patients August 01, 2016 By Tracey Walker Surveys conducted by the AACE with support from Sanofi US, identified differences in perceptions among adults living with type 2 diabetes. What healthcare professionals don't know may surprise you. Telemonitoring reduces diabetes patients’ blood sugar levels October 28, 2015 By Christine Blank A pharmacist-led telemonitoring program reduced blood sugar levels in diabetics, according to a new study. Essure and the risks of reoperation A new study examines the risk:benefit of the Essure device. And, does anti-osteoporosis medication in the wake of a fragility fracture reduce the risk of a future fracture? Plus: What role do high maternal blood glucose levels play in her child's future cardiovascular health? FDA approves Synjardy for type 2 diabetes August 31, 2015 By Erin Bastick FDA has approved empagliflozin and metformin hydrochloride (Synjardy, Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company) tablets for the treatment of adults with type 2 diabetes. "Smart" patch may eliminate need for insulin shots in diabetics June 23, 2015 A new, painless “smart insulin patch” lowered blood glucose in a mouse model of type 1 diabetes for up to 9 hours, according to a study published in the Proceedings of the National Academy of Sciences. FDA approves breath test to help diagnose gastroparesis April 08, 2015 By Erin Bastick The FDA has approved the Gastric Emptying Breath Test (GEBT), manufactured by Advanced Breath Diagnostics, a new, non-invasive test used to help diagnose gastroparesis.